Biggest News Aggregation in the World
📰 Equity Subscription News

Equity Subscription News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Equity Subscription. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

21st Austria weekly - Valneva; AT&S (20/06/2022)

21st Austria weekly - Valneva; AT&S 20/06/2022 [pic1]Valneva: Austrian/French vaccine company Valneva and Pfizer announced that they have entered into an Equity Subscription Agreement updated the terms of their Collaboration License for Lyme disease candidate VLA15. As previously on April 26 2022 plans to initiate Phase 3 study VLA15 in third quarter 2022. part Agreement
Equity Subscription Agreement License Agreement Euronext Paris Equity Subscription Austria Weekly Partner Asset Management Gmbh

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science